138 related articles for article (PubMed ID: 1524986)
1. High-dose melphalan, etoposide, and carboplatin (MEC) +/- fractionated total body irradiation for treatment of advanced solid tumors.
Gadner H; Emminger W; Ladenstein R; Peters C
Pediatr Hematol Oncol; 1992; 9(2):v-viii. PubMed ID: 1524986
[No Abstract] [Full Text] [Related]
2. Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor.
Emminger W; Gadner H
Pediatr Hematol Oncol; 1992; 9(2):183-5. PubMed ID: 1356004
[No Abstract] [Full Text] [Related]
3. Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity?
Emminger W; Emminger-Schmidmeier W; Peters C; Hawliczek R; Höcker P; Gadner H
Bone Marrow Transplant; 1991 Aug; 8(2):119-23. PubMed ID: 1933052
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Ozkaynak MF; Sahdev I; Gross TG; Levine JE; Cheerva AC; Richards MK; Rozans MK; Shaw PJ; Kadota RP
J Pediatr Hematol Oncol; 2008 Mar; 30(3):204-9. PubMed ID: 18376282
[TBL] [Abstract][Full Text] [Related]
5. High-dose melphalan, etoposide +/- carboplatin (MEC) combined with 12-gray fractionated total-body irradiation in children with generalized solid tumors.
Emminger W; Emminger-Schmidmeier W; Hawliczek R; Peters C; Höcker P; Gadner H
Pediatr Hematol Oncol; 1991; 8(1):13-22. PubMed ID: 2029464
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma.
Corbett R; Pinkerton R; Pritchard J; Meller S; Lewis I; Kingston J; McElwain T
Eur J Cancer; 1992; 28A(8-9):1324-8. PubMed ID: 1515243
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma.
Gordon SJ; Pearson AD; Reid MM; Craft AW
Eur J Cancer; 1992; 28A(8-9):1319-23. PubMed ID: 1515242
[TBL] [Abstract][Full Text] [Related]
8. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
Lam-Po-Tang PR; McCowage GB; Vowels MR
Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
[No Abstract] [Full Text] [Related]
9. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
[TBL] [Abstract][Full Text] [Related]
10. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
11. Tandem high-dose chemotherapy with autologous stem cell rescue for stage M high-risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens.
Kato S; Kubota Y; Watanabe K; Hogetsu K; Arakawa Y; Koh K; Takita J; Hiwatari M
Pediatr Transplant; 2020 Nov; 24(7):e13772. PubMed ID: 32543778
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
13. Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
Seeger RC; Villablanca JG; Matthay KK; Harris R; Moss TJ; Feig SA; Selch M; Ramsay N; Reynolds CP
Prog Clin Biol Res; 1991; 366():527-33. PubMed ID: 2068169
[No Abstract] [Full Text] [Related]
14. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
[TBL] [Abstract][Full Text] [Related]
15. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
Ozkaynak MF; Matthay K; Cairo M; Harris RE; Feig S; Reynolds CP; Buckley J; Villablanca JG; Seeger RC
J Clin Oncol; 1998 Mar; 16(3):937-44. PubMed ID: 9508176
[TBL] [Abstract][Full Text] [Related]
16. Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue.
Burdach S; Peters C; Paulussen M; Nürnberger W; Wurm R; Wernet P; Dilloo D; Voehringer R; Gadner H; Göbel U
Bone Marrow Transplant; 1991; 7 Suppl 2():95. PubMed ID: 1678978
[No Abstract] [Full Text] [Related]
17. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
[TBL] [Abstract][Full Text] [Related]
18. High dose etoposide melphalan, total body irradiation and ABMT for acute myeloid leukemia in first remission.
Keating A; Crump M
Leukemia; 1992 Nov; 6 Suppl 4():90-1. PubMed ID: 1434843
[No Abstract] [Full Text] [Related]
19. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
20. Perspectives for the use of high-dose chemotherapy in the treatment of solid malignant tumors.
Sculier JP; Klastersky J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1335-7. PubMed ID: 6389145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
